Francisco Gascón

739 total citations
30 papers, 462 citations indexed

About

Francisco Gascón is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Francisco Gascón has authored 30 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 11 papers in Neurology and 8 papers in Oncology. Recurrent topics in Francisco Gascón's work include Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (8 papers) and Polyomavirus and related diseases (6 papers). Francisco Gascón is often cited by papers focused on Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (8 papers) and Polyomavirus and related diseases (6 papers). Francisco Gascón collaborates with scholars based in Spain. Francisco Gascón's co-authors include Bonaventura Casanova, Francisco Pérez‐Miralles, Carmen Alcalá, Sara Gil‐Perotín, Isabel Boscá, Francisco Coret, Virginia Meca‐Lallana, Laura Cubas-Núñez, Joan Carreres Polo and Ángela Vidal‐Jordana and has published in prestigious journals such as Journal of Neurology, Lung Cancer and Acta Neurologica Scandinavica.

In The Last Decade

Francisco Gascón

29 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francisco Gascón Spain 13 338 139 99 67 63 30 462
Lynn Stazzone United States 9 431 1.3× 152 1.1× 91 0.9× 82 1.2× 75 1.2× 10 530
Elisabetta Verdun di Cantogno United States 11 380 1.1× 139 1.0× 93 0.9× 36 0.5× 98 1.6× 23 437
Vana Tsimourtou Greece 12 262 0.8× 117 0.8× 123 1.2× 49 0.7× 65 1.0× 20 475
Jacqueline Nicholas United States 12 370 1.1× 110 0.8× 108 1.1× 88 1.3× 86 1.4× 47 507
Johannes Lorscheider Switzerland 12 434 1.3× 145 1.0× 127 1.3× 95 1.4× 79 1.3× 28 557
Mark Slee Australia 12 257 0.8× 214 1.5× 111 1.1× 91 1.4× 62 1.0× 41 518
Aurora Zanghì Italy 16 462 1.4× 169 1.2× 174 1.8× 87 1.3× 117 1.9× 50 648
Alessandra Murialdo Italy 9 259 0.8× 113 0.8× 92 0.9× 45 0.7× 53 0.8× 12 383
Mattias Vågberg Sweden 10 384 1.1× 230 1.7× 110 1.1× 64 1.0× 73 1.2× 14 617
Alessandro Dinoto Italy 12 229 0.7× 312 2.2× 86 0.9× 50 0.7× 72 1.1× 51 514

Countries citing papers authored by Francisco Gascón

Since Specialization
Citations

This map shows the geographic impact of Francisco Gascón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Gascón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Gascón more than expected).

Fields of papers citing papers by Francisco Gascón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Gascón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Gascón. The network helps show where Francisco Gascón may publish in the future.

Co-authorship network of co-authors of Francisco Gascón

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Gascón. A scholar is included among the top collaborators of Francisco Gascón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Gascón. Francisco Gascón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Insa, Amelia, et al.. (2025). Use of immune checkpoint inhibitors in patients with lung cancer and multiple sclerosis. Lung Cancer. 202. 108464–108464.
2.
Cubas-Núñez, Laura, et al.. (2024). Comparative Assessment of Simoa and Lumipulse for Measuring Serum Neurofilament Light Chain in Multiple Sclerosis Patients. Acta Neurologica Scandinavica. 2024(1). 1 indexed citations
3.
Casanova, Bonaventura, et al.. (2022). Escalation vs. Early Intense Therapy in Multiple Sclerosis. Journal of Personalized Medicine. 12(1). 119–119. 22 indexed citations
4.
Gascón, Francisco, et al.. (2022). Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series. Frontiers in Neurology. 13. 897275–897275. 9 indexed citations
5.
Alcalá, Carmen, Francisco Gascón, Ángel Pérez Sempere, et al.. (2022). Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study. Journal of Neurology. 269(7). 3676–3681. 12 indexed citations
6.
Gascón, Francisco, Joan Carreres Polo, Sara Gil‐Perotín, et al.. (2022). Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis. Frontiers in Neurology. 13. 991596–991596. 2 indexed citations
7.
Pérez‐Miralles, Francisco, Daniel Prefasi, Antonio Garcı́a-Merino, et al.. (2021). Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis. Brain and Behavior. 11(4). e02044–e02044. 5 indexed citations
8.
Gascón, Francisco, et al.. (2021). Rituximab para el tratamiento de la miastenia grave generalizada: experiencia en la práctica clínica. Revista de Neurología. 73(12). 416–416. 3 indexed citations
9.
Landete, Lamberto, Francisco Pérez‐Miralles, Antonio Belenguer, et al.. (2021). Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain. Frontiers in Neurology. 12. 727586–727586. 5 indexed citations
10.
Pérez‐Miralles, Francisco, Daniel Prefasi, Antonio Garcı́a-Merino, et al.. (2021). Short-term data on disease activity, cognition, mood, stigma and employment outcomes in a cohort of patients with primary progressive multiple sclerosis (UPPMS study). Multiple Sclerosis and Related Disorders. 50. 102860–102860. 16 indexed citations
11.
Meca‐Lallana, Virginia, et al.. (2021). Cognitive impairment in multiple sclerosis: diagnosis and monitoring. Neurological Sciences. 42(12). 5183–5193. 74 indexed citations
12.
Gil‐Perotín, Sara, Laura Cubas-Núñez, David Hervás, et al.. (2019). Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis. Frontiers in Neurology. 10. 1008–1008. 61 indexed citations
13.
Casanova, Bonaventura, Francisco Gascón, David Hervás, et al.. (2018). Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients. Neurological Sciences. 39(8). 1423–1430. 5 indexed citations
14.
Coret, Francisco, Francisco Pérez‐Miralles, Francisco Gascón, et al.. (2018). Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies. Multiple Sclerosis Journal - Experimental Translational and Clinical. 4(2). 2453203315–2453203315. 26 indexed citations
15.
Alcalá, Carmen, et al.. (2018). Recurrent and universal alopecia areata following alemtuzumab treatment in multiple sclerosis: A secondary autoimmune disease. Multiple Sclerosis and Related Disorders. 27. 406–408. 17 indexed citations
16.
Gil‐Perotín, Sara, et al.. (2018). Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report. Frontiers in Neurology. 9. 340–340. 3 indexed citations
17.
Alcalá, Carmen, Francisco Gascón, Francisco Pérez‐Miralles, et al.. (2018). Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study. Journal of Neurology. 265(7). 1690–1697. 47 indexed citations
18.
Pérez‐Miralles, Francisco, et al.. (2017). Tratamiento de la esclerosis múltiple remitente recurrente con fingolimod en la práctica clínica habitual. Revista de Neurología. 64(10). 445–445. 4 indexed citations
19.
Casanova, Bonaventura, Isidro Jarque, Francisco Gascón, et al.. (2017). Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis. Neurological Sciences. 38(7). 1213–1221. 40 indexed citations
20.
Rı́os, Ramón, et al.. (1996). t(2;3) in a case of blastic transformation of essential thrombocythaemia.. PubMed. 92(3). 769–70. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lynn Stazzone Breakdown of academic impact, for papers by Elisabetta Verdun di Cantogno Breakdown of academic impact, for papers by Vana Tsimourtou Breakdown of academic impact, for papers by Jacqueline Nicholas Breakdown of academic impact, for papers by Johannes Lorscheider Breakdown of academic impact, for papers by Mark Slee Breakdown of academic impact, for papers by Aurora Zanghì Breakdown of academic impact, for papers by Alessandra Murialdo Breakdown of academic impact, for papers by Mattias Vågberg Breakdown of academic impact, for papers by Alessandro Dinoto
Rankless by CCL
2026